GenArraytion is a biotechnology company with paradigm-shifting products and services that will dramatically impact the quality and speed of infectious disease diagnosis and, thus, medical treatment.
A novel approach enables us to rapidly develop and produce high fidelity, high throughput diagnostics for a wide range of infectious disease-related conditions, including those that are newly emerging or poorly characterized. These competencies are being used to create rapid turn-around, accurate, reliable diagnostics for pathogen identification and antibiotic susceptibility characterization. Products and services based on these discriminators are applicable to medical and veterinary diagnostics, as well as epidemiological, environmental, food and water monitoring.
GenArraytion established itself as an independent company in 2007.
GenArraytion is actively registered in the Central Contractor Registration (CCR) database and is ORCA certified.